Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

NCT05304468 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

452

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

RADIATION: IMRT
DRUG: induction chemotherapy
DRUG: cisplatin concurrent chemotherapy

Sponsor

Sun Yat-sen University